Comparison of two malignancy risk indices based on serum CA125, ultrasound score and menopausal status in the diagnosis of ovarian masses

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 106, Issue 6, 1999, Pages 524-527

  Morgante, Giuseppe ^a   La Marca, Antonio ^a   Ditto, Antonino ^a   De Leo, Vincenzo ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN;

ADULT; ARTICLE; CANCER RISK; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; ECHOGRAPHY; FEMALE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MENOPAUSE; OVARY CANCER; OVARY TUMOR; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT;

ADULT; AGED; CA-125 ANTIGEN; FEMALE; HUMANS; MENOPAUSE; MIDDLE AGED; OVARIAN NEOPLASMS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 0033056562     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1999.tb08318.x     Document Type: Article

References (18)

1. Gillis CR, Hole DJ, Still RM, Davis J, Kaye SB. Medical audit, cancer registration, and survival in ovarian cancer. Lancet 1991; 337: 611–612.
2. Finkler NJ, Benacerraf B, Lavin PT, Wojcichhowski C, Knapp RC. Comparison of serum CA125, clinical impression, and ultrasound in the preoperative evaluation of ovarian masses. Obstet Gynecol 1988; 72: 659–664.
3. Vasilev SA, Schlaerth JB, Campeau J, Morrow CP. Serum CA125 levels in preoperative evaluation of pelvic masses. Obsfer Gynecol 1988; 71: 751–756.
4. The Surveillance Program, Division of Cancer Prevention and Control. Cancer Statistics Review 1973–1987 [publication no: 90–27891. Washington DC : National Cancer Institute, 1988.
5. Schwartz PE, Moms JM. Serum lactic dehydrogenase: A tumor marker for dysgerminoma. Obstet Gynecol 1988; 72: 511–515.
6. Williams SD, Gershenson DM, Horowitz CJ, Scully RE. Ovarian germ cell and stromal tumors. In: Hoskins WJ, Perez CA, Young RC, editors. Principles and Practice of Gynecologic Oncology. Philadelphia : JB Lippincott, 1992: 715–730.
7. Valentin L, Sladkevicius P, Marsal K. Limited contribution of Doppler velocimetry to the differential diagnosis of extrauterine pelvic tumors. Obstet Gynecol 1994; 83: 425–433.
8. Schneider VL, Schneider A, Reed KL, Hatch KD. Comparison of doppler with two-dimensional sonography and CAI 25 for prediction of malignancy of pelvic masses. Obstet Gynecol 1993; 81: 983–988.
9. Granberg S, Norstrom A, Wikland M. Tumors in the pelvis as imaged by vaginal sonography. Gynecol Oncol 1990; 37: 224–226.
10. Kujak A, Pradanijc M. New scoring system for prediction of ovarian malignancy based on transvaginal color Doppler sonography. J Ultrasound Med 1992; 11: 631–638.
11. Sassone AM, Timor-Tritsch IE, Artner A, Westhoff C, Warren WB. Transvaginal sonographic characterization of ovarian disease: Evaluation of a new scoring system to predict ovarian malignancy. Obstet Gynecol 1991; 78: 70–76.
12. Jacobs I, Oram D, Fairbanks J, Turner J, Frost C, Grudzinskas JG. A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer. Br J Obsret Gynaecol 1990; 97: 922–929.
13. Tingulstad S, Hagen B, Skjeldestad FE et al. Evaluation of a risk of malignancy index based on serum CA125, ultrasound findings and menopausal status in the pre-operative diagnosis of pelvic masses. Br J Obstet Gynaecol 1996; 103: 826–831.
14. Patsner B, Mann WJ. The value of preoperative serum CA125 levels in patients with a pelvic mass. Am J Obsret Gynecol 1988; 159: 873–876.
15. Malkasian GD, Knapp RC, Lavin PT, Zurawski VR Jr, Podratz KC. Preoperative evaluation of serum CA125 levels in premenopausal and postmenopausal patients with pelvic masses: Discrimination of benign from malignant disease. Am J Obstet Gynecol 1988; 159: 341–346.
16. Jacobs IJ, Rivera H, Oram DH, Bast RC. Differential diagnosis of ovarian cancer with tumor markers CA125. CA 15–3 and TAG 72.3. Br J Obstet Gynaecol 1993; 100: 1120–1124.
17. Roman LD, Muderspach LI, Stein SM, Laifer-Narin S, Groshen S, Morrow CP. Pelvic examination, tumor marker level, and gray-scale and Doppler sonography in the prediction of pelvic cancer. Obstet Gynecol 1997; 89: 493–500.
18. Davies AP, Jacobs I, Woolas R, Fish A, Oram D. The adnexal mass: benign or malignant? Evaluation of a risk of malignancy index. Br J Obstet Gynaecol 1993; 100: 927–931.